Brochure
10 Oct 2023

Think Almac...Preformulation development

PDF 194 kB
Download

As a world leader in pharmaceutical services, Almac delivers early formulation development workprograms for DRF/PK/tox studies. Designed to maximise solubility and bioavailability withoutcompromising on chemical stability, the studies accelerate drug development to the clinic and minimizerisk in any downstream activities. Almac offer bespoke work packages specifically tailored to thephysiochemical properties of the API (BCS class II, III, or IV) for solubility or permeability enhancement.

Read more Show less
Content provided by our supplier

Almac Group Ltd

  • GB
  • 2015
    On CPHI since
  • 4
    Certificates
  • 5000+
    Employees
Company types
CMO/CDMO
Contract Service
Manufacturer/Innovator
Packaging supplier/manufacturer
Primary activities
Analytical Services
API Producer
Biopharmaceutical
Chemical Development
Contract Manufacturer
Custom Manufacturing/Custom Synthesis
Fine Chemicals Company
Intermediates Manufacturer
Laboratory Services
Other
Packaging & drug delivery
Supply Chain
Transport/Logistics/Distribution
View company profile

Other Content from Almac Group Ltd (16)